Related Experiment Video
Updated: Aug 18, 2026

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Early Antiviral Therapy in Pediatric Outpatients and Risk of Influenza-Related Hospitalization
Ya-Ning Huang1,2,3, Chia-Jung Chang4, Yu-Ling Dai1,2
1Department of Pediatrics, Hsinchu Municipal MacKay Children's Hospital, Hsinchu, Taiwan.
Insights
Early antiviral therapy significantly lowers hospitalization risk for children with influenza. Prompt treatment within 48 hours of symptom onset is crucial for preventing severe illness in pediatric patients.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Pharmacotherapy
Background:
- Limited evidence exists on antiviral therapy's effectiveness in preventing severe influenza illness and hospitalization in children.
- Influenza poses a significant risk for severe outcomes in pediatric populations.
Purpose of the Study:
- To evaluate the effectiveness of early antiviral therapy in reducing severe illness and hospitalization in pediatric influenza patients.
- To test the hypothesis that antiviral treatment initiated within 48 hours of symptom onset improves outcomes.
Main Methods:
- A multicenter, retrospective case-control study involving pediatric outpatients with confirmed influenza (2020-2023).
- Cases were hospitalized or deceased children; controls were non-hospitalized children, matched by age and visit date.
- Conditional logistic regression analyzed early (within 48 hours) vs. delayed/no antiviral therapy.
Main Results:
- Early antiviral therapy was associated with an 81% reduced risk of hospitalization (aOR, 0.19).
- This protective effect was consistent across age groups: 5 years or younger (aOR, 0.19) and older than 5 years (aOR, 0.15).
- Sensitivity analyses confirmed the robustness of these findings across different antiviral agents.
Conclusions:
- Early antiviral therapy substantially decreases the risk of severe illness and hospitalization in pediatric influenza patients.
- The findings support the prompt initiation of antiviral treatment for children diagnosed with influenza.
Objectives:
Evidence on the effectiveness of antiviral therapy in preventing influenza-related severe illness and hospitalization among children remains limited. We hypothesized that early administration of antiviral therapy within 48 hours of symptom onset would significantly reduce the risk of subsequent influenza-related severe illness and hospitalization.
Methods:
This multicenter, age- and season-matched, retrospective case-control study included all pediatric outpatients with laboratory-confirmed influenza who sought care at the participating hospitals between 2020 and 2023. Cases were defined as children subsequently hospitalized or deceased because of influenza and were matched to nonhospitalized controls by date of initial visit and age strata. The effectiveness of early antiviral therapy (initiated within 48 hours of symptom onset, compared with delayed or no use) was estimated using conditional logistic regression. Subgroup analyses were performed for children aged 5 years or younger and older than 5 years.
Results:
Among 1492 children (354 cases and 1138 controls; mean age, 7.1 years), early antiviral therapy was associated with an 81% lower risk of hospitalization overall (adjusted odds ratio [aOR], 0.19; 95% CI, 0.14-0.27), with similar protection among children aged 5 years or younger (aOR, 0.19; 95% CI, 0.12-0.31) and older than 5 years (aOR, 0.15; 95% CI, 0.09-0.25). The effect remained robust across sensitivity analyses by antiviral agent, with E-values up to 10.0 (range, 9.47-19.49 across subgroups).
Conclusions:
Early antiviral therapy in pediatric outpatients with influenza substantially reduces the risk of subsequent severe illness and hospitalization, supporting prompt initiation of treatment in this population.
More Related Videos
Related Concept Videos
Respiratory Syncytial Virus Disease
Influenza
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

